January 12, 2011 02:27 ET

DSM discloses shareholding in Danisco

HEERLEN, NETHERLANDS--(Marketwire - January 12, 2011) - Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that it holds a 4.95% stake in Danisco which has been acquired some years ago.

DSM currently owns 2.36 million shares of Danisco, which are traded at the Copenhagen Stock Exchange. It has been building its shareholding in 2007 and beginning 2008.

DSM has taken notice of the recommended bid that has been announced by DuPont at a price of DKK 665 per share. If DSM sells its shares for DKK 665, it will have a non-recurring book profit of approximately EUR 129 million before tax.

DSM is not considering a competitive bid.

DSM - the Life Sciences and Materials Sciences Company

Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel. DSM has annual net sales of about EUR8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information:

Press release-pdf:

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: DSM N.V. via Thomson Reuters ONE


Contact Information

  • For more information:

    DSM Corporate Communications

    Herman Betten

    tel. +31 (0) 45 5782017

    fax +31 (0) 45 5740680

    e-mail Email Contact

    DSM Investor Relations

    Hans Vossen

    tel. +31 (0) 45 5782864

    fax +31 (0) 10 4590275
    e-mail Email Contact